Inventiva (IVA) Depreciation & Amortization (CF) (2019 - 2022)
Inventiva (IVA) posted quarterly Depreciation & Amortization (CF) of -$4.4 million for Q2 2025, down 17.5% year-over-year from -$5.4 million in Q2 2024, and down 6.17% quarter-over-quarter from -$4.2 million in Q4 2024.
Analysis
Inventiva (IVA) Depreciation & Amortization (CF) (2019 - 2022) Analysis & Trends
Inventiva's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at -$4.4 million for Q2 2025.
- In Q2 2025, Depreciation & Amortization (CF) fell 17.5% year-over-year to -$4.4 million; the TTM figure through Dec 2025 stood at $1.3 million (up 131.45% YoY), while the FY2024 annual figure was -$4.2 million, down 14.43% from the prior year.
- Depreciation & Amortization (CF) for Q2 2025 stood at -$4.4 million, down from -$4.2 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $662584.1 in Q3 2022, with the low at -$4.4 million in Q2 2025.
- The 5-year median for Depreciation & Amortization (CF) is -$1.6 million (2021), against an average of -$1.7 million.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) gained 6.05% in 2022, then sank 662.0% in 2023.
- Inventiva's Depreciation & Amortization (CF) stood at $610880.5 in 2021, then increased by 6.05% to $647857.1 in 2022, then slumped by 662.0% to -$3.6 million in 2023, then dropped by 14.43% to -$4.2 million in 2024, then slipped by 6.17% to -$4.4 million in 2025.
- Business Quant data shows IVA's Depreciation & Amortization (CF) at -$4.4 million in Q2 2025, -$4.2 million in Q4 2024, and -$3.8 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 56.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 123.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 40.52 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Inventiva | 893.85 Mn | 893.85 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 647,857.08 |
| Sep 22, 2022 | 662,584.15 |
| Dec 31, 2021 | 610,880.49 |
| Jun 30, 2021 | 276,982.43 |
| Mar 31, 2021 | 366,695.78 |
| Dec 31, 2020 | 795,257.33 |
| Jun 30, 2020 | 363,481.84 |
| Mar 31, 2020 | 372,027.45 |
| Dec 31, 2019 | 649,743.06 |